Skip to main content
Premium Trial:

Request an Annual Quote

Sphere Fluidics Raises $40M in VC Funding

NEW YORK – UK single-cell analysis instrument maker Sphere Fluidics said on Thursday that it has closed a $40 million investment round.

Sofinnova Partners and Redmile Group led the round. Sphere said it will use the funding to expand its international sales activities, to improve customer support, and for research and development, including novel applications for its Cyto-Mine single-cell analysis system.

"We remain impressed by Cyto-Mine's high throughput, ease of use, and accessible cost," Tom Burt, a partner at Sofinnova, said in a statement. "In the growing markets of monoclonal antibody discovery, cell line development, and cell therapy, we see a significant need for such an affordable and reliable single-cell analysis system as Cyto-Mine, capable of performing multiple assays on tens of millions of individual cells per run."

Cambridge, UK-based Sphere is automating single-cell analysis for pharmaceutical development with Cyto-Mine, a platform launched in 2017 that integrates single-cell screening, sorting, dispensing, imaging, and clone verification. The firm raised a total of $6.8 million in 2019 across two funding tranches.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.